PARIS (AFP) — There were no positive doping tests at this year’s Tour de France, the Cycling Anti-Doping Foundation (CADF) announced Tuesday, on behalf of the UCI, as well as the UK and French anti-doping agencies.
“All the samples collected were systematically analyzed to detect stimulants and erythropoiesis,” said the UCI, the latter being the process which produces red blood cells.
“Isotope-ratio mass spectrometry (IRMS) was also analyzed in a certain number of samples, in particular to detect testosterone abuse and its precursors.”
A total of 719 blood and urine samples were taken in this year’s Tour, compared to 622 a year ago, with the testing carried out at the WADA-accredited laboratory of Châtenay-Malabry in France.
Of these samples, 197 were collected pre-competition for the purposes of the biological passport and medical monitoring, and another 522 were taken during the race.
Additionally, all riders in the Tour were subject to a simultaneous, unannounced biological passport test during the rest day in Carcassonne.
“I would like to thank the anti-doping bodies involved in the 2014 Tour de France operations for their collaboration, in particular the French Anti-Doping Agency and UK Anti-Doping, but also the World Anti-Doping Agency and the CADF,” said UCI president Brian Cookson. “This sort of collaboration is absolutely necessary. Thanks to a sharing of information, the effectiveness of the testing distribution and therefore the overall anti-doping program is improved, with the stakeholders sharing their knowledge, their know-how and the information they have available. In addition, it increases the program’s transparency while obviously respecting the confidentiality regulations in force.”